Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion.
Nishi K, Ishikura S, Umebayashi M, Morisaki T, Inozume T, Kinugasa T, Aoki M, Nimura S, Swain A, Yoshida Y, Hasegawa S, Nabeshima K, Sakata T, Shirasawa S, Tsunoda T.
Nishi K, et al. Among authors: tsunoda t.
Anticancer Res. 2020 Aug;40(8):4663-4674. doi: 10.21873/anticanres.14465.
Anticancer Res. 2020.
PMID: 32727790